2,3,4-Trimethoxyacetophenone

CAS No. 13909-73-4

2,3,4-Trimethoxyacetophenone( —— )

Catalog No. M37835 CAS No. 13909-73-4

2',3',4'-Trimethoxyacetophenone is a raw material for the preparation of chalcone compounds with anti-inflammatory activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 45 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    2,3,4-Trimethoxyacetophenone
  • Note
    Research use only, not for human use.
  • Brief Description
    2',3',4'-Trimethoxyacetophenone is a raw material for the preparation of chalcone compounds with anti-inflammatory activity.
  • Description
    2',3',4'-Trimethoxyacetophenone is a raw material for the preparation of chalcone compounds with anti-inflammatory activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    13909-73-4
  • Formula Weight
    210.23
  • Molecular Formula
    C11H14O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1ccc(C(C)=O)c(OC)c1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CFM 4

    CFM 4 is a potent small molecule CARP-1/APC-2 antagonist that prevents CARP-1 from binding to APC-2, contributes to G2M cell cycle arrest, and induces apoptosis, with an IC50 in the range of 10-15 μM.

  • Glaucine

    Glaucine has antitussive antioxidative potential and antiviral activities it may be an anti-arthritic agent it can enhance LPS and zymosan-induced IL-10 production. Glaucine can inhibit the migration and invasion of human breast cancer cells by MMP-9 inhibitory activity attenuating IκBα and NF-κB activities.

  • Sophocarpine monohyd...

    Sophocarpine, a major ingredient of Sophora alopecuroides, has a wide range of pharmacological effects.